Keywords: |
clinical trial; review; antineoplastic agents; comparative study; antineoplastic agent; neoplasm; neoplasms; animal; metabolism; animals; cell cycle; apoptosis; classification; neoplasm proteins; transcription factor; drug effect; drug screening; enzymology; drug screening assays, antitumor; enzyme inhibitor; physiology; transcription factors; gene expression regulation; gene expression regulation, neoplastic; drug antagonism; protein processing; protein processing, post-translational; species specificity; saccharomyces cerevisiae; enzyme inhibitors; histone; chromatin; tumor protein; transactivation; neoplasms, experimental; forecasting; species difference; models, molecular; chemical structure; gene silencing; experimental neoplasm; saccharomyces cerevisiae proteins; saccharomyces cerevisiae protein; histones; histone deacetylases; ultrastructure; clinical trials; histone deacetylase; acetylation; nucleosome; nucleosomes; trans-activation (genetics); humans; human; male; female
|